Virax Biolabs Group Limited financial statements, including revenue, expenses, profit, and loss

The total revenue of VRAX for the last semiannual is 76.50 k USD, and it's 2631.17% higher compared to the previous semiannual. The net income of H1 23 is -2.91 M USD.